Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q2 2022 call → NOThe question asks whether management explains where the company's business is going by narrating what its counterparties are themselves doing and scaling. Let me analyze the transcript carefully. The company is SelectQuote, a Medicare Advantage distribution company. The call discusses their disappointing quarter, challenges with AEP (Annual Enrollment Period), and their strategy going forward. Key elements of management's forward account: 1. They discuss resetting their growth philosophy, pulling back on submissions 2. They discuss changes to LTV assumptions 3. They discuss SelectRx (their pharmacy business) growth - 40,000 enrollments, 10,000 active members 4. They discuss operational changes - hiring earlier, reducing flex agents Now, do they narrate what their counterparties (carriers, insurers, partners) are doing and scaling? Let me look for this. The counterparties here would be the insurance carriers (like Humana, etc.) that SelectQuote distributes for. Management discusses: - Plan parity among carriers - Carrier plan design changes - Competition in the market But do they describe carriers' own growth trajectories, ramps, launches, or build-outs as the driver of SelectQuote's coming activity? No. They describe the carriers' plan designs as a headwind (parity), not as a growth driver. For SelectRx, the counterparties would be... well, SelectRx is their own pharmacy business. The "counterparties" there would be the members/customers, but that's their own customer base, not a counterparty whose growth drives them. The question asks about "counterparties" - customers, partners, licensees, distributors, payers, operators, or programs the company ALREADY SUPPLIES OR SERVES. For SelectQuote, the carriers are the ones they serve (they distribute carrier plans). But management doesn't describe carriers' own expansion plans as driving SelectQuote's growth. Management's forward account is about: - Their own operational changes (hiring earlier, reducing headcount) - Their own LTV assumption changes - Their own SelectRx ramp - Their own cost structure They don't narrate what carriers are doing to scale up and how that drives SelectQuote. They mention plan parity as a problem, not as a growth driver. The SelectRx discussion is about their own business ramp - they're building it themselves.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.